Related Experiment Video
Updated: Nov 17, 2025

09:04
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
10.0K
Vascular Endothelial Protein Tyrosine Phosphatase Regulates Endothelial Function
1Max Planck Institute of Molecular Biomedicine, Münster, Germany.
Physiology (Bethesda, Md.)
|February 17, 2021
Summary
Vascular endothelial protein tyrosine phosphatase (VE-PTP) regulates blood vessel formation and function by interacting with key proteins like Tie-2 and VE-cadherin. Targeting VE-PTP offers therapeutic potential for various diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Vascular Biology
Background:
- Vascular endothelial protein tyrosine phosphatase (VE-PTP) is a receptor-type PTP (RPTP) primarily found in vascular endothelial cells.
- VE-PTP plays a critical role in embryonic and tumor angiogenesis, vascular permeability, and homeostasis during inflammation.
Purpose of the Study:
- To review the mechanisms by which VE-PTP controls vascular functions through its substrates.
- To explore the therapeutic potential of targeting VE-PTP in various pathophysiological conditions.
Main Methods:
- Literature review of studies on VE-PTP function and substrates.
- Analysis of VE-PTP's role in angiogenesis, vascular permeability, and inflammation.
- Evaluation of therapeutic strategies targeting VE-PTP.
Main Results:
- VE-PTP dephosphorylates key substrates including the tyrosine kinase receptor Tie-2 and the adhesion molecule VE-cadherin.
- Dysregulation of VE-PTP impacts vascular development and disease states.
- VE-PTP is implicated in regulating endothelial cell behavior and vascular integrity.
Conclusions:
- VE-PTP is a crucial regulator of vascular endothelial cell functions.
- Modulating VE-PTP activity presents a promising therapeutic avenue for vascular-related diseases.
- Further research into VE-PTP substrates and signaling pathways is warranted.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Transducer Mechanism: Enzyme-Linked Receptors
3.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.5K
Receptor Downregulation in MVBs
2.5K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.5K
Amplifying Signals via Enzymatic Cascade
15.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.2K
Receptor Tyrosine Kinases
16.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
16.3K
Mechanism of Angiogenesis
6.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K

